THE APPETITE CONTROLLER

Semaglutide

Grade B — Good

Take control of your appetite and transform your body with proven science.

Also known as: Ozempic; Wegovy; Rybelsus

Metabolic Modulator
Weight Management
Cardiovascular Support
Appetite & Metabolic Control

Overview

Semaglutide is an FDA-approved GLP-1 receptor agonist that has transformed treatment of obesity and type 2 diabetes. It works by mimicking the hormone GLP-1 to reduce appetite, slow stomach emptying, and improve insulin sensitivity. In trials, it produced 15% weight loss and significantly reduced cardiovascular events. Available as weekly injection (Ozempic/Wegovy) or daily oral tablet (Rybelsus).

Key Benefits & Mechanisms

Appetite Suppression

Activates hypothalamic POMC neurons to reduce hunger

Insulin Enhancement

Stimulates glucose-dependent insulin secretion

Gastric Slowing

Delays stomach emptying for prolonged fullness

Cardioprotection

Reduces cardiovascular events and inflammation

Dosing Guide

Dosage

Injection: Start 0.25 mg weekly, titrate to 1-2.4 mg weekly. Oral: Start 3 mg daily, up to 14 mg daily

Schedule

weekly

Cycle

Ongoing as prescribed

Pro Tip

Titrate slowly over months to minimize GI side effects; take oral on empty stomach

This peptide requires titration — start with a lower dose and increase gradually.

Safety Profile

B

Good Safety

Good

FDA-approved with well-characterized side effects. GI issues are common but manageable.

Contraindicated in medullary thyroid cancer or MEN 2 syndrome. May cause pancreatitis.

Possible Side Effects

Nausea
Vomiting
Diarrhea
Constipation
Injection site reactions

What to Expect

Week 1-4

Reduced appetite and food cravings; GI adjustment

Month 1-3

5-7% body weight loss; improved blood sugar

Month 3-6

10-12% body weight loss; metabolic improvements

Month 6-12

15%+ body weight loss; sustained metabolic benefits

Weight loss typically begins within 2-4 weeks; continues for 12+ months.

Who Is This For

Those with type 2 diabetes
People with BMI over 30 (obesity)
Those with BMI over 27 with weight-related conditions
Anyone wanting proven, FDA-approved weight loss
Those at high cardiovascular risk

Research References

[1]STEP Trials - Wegovy Weight Loss Data[2]SUSTAIN Trials - Ozempic Diabetes Data

Related Peptides

5-Amino-1MQ

B

THE FAT BURNER

Boost metabolism and burn fat without changing your diet

ACE-031

C

THE MUSCLE UNLEASHED

Block the muscle-limiting signal and unlock serious gains

AICAR

C

THE EXERCISE MIMETIC

Exercise in a molecule - activate your metabolism without the gym

AOD-9604

A

THE FAT MOBILIZER

The fat-burning piece of growth hormone - without the side effects

Apelin-12

B

THE HEART OPTIMIZER

Heart-boosting peptide for better blood flow and energy

ARA-290

B

THE NERVE HEALER

Nerve repair and pain relief without affecting blood cells

Ready to Start Your Peptide Journey?

Track your protocols, get guided reconstitution, and access our vetted vendor network — all in one app.

Download The Peptide App